Exelixis (EXEL) Depreciation & Amortization (CF) (2010 - 2026)

Exelixis' (EXEL) quarterly Depreciation & Amortization (CF) came in at $6.9 million in Q2 2026, down 5.41% year-on-year from $7.3 million in Q2 2025, and little changed quarter-over-quarter from $6.9 million in Q1 2026.

Exelixis (EXEL) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Exelixis' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $6.9 million for Q2 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 5.41% year-over-year to $6.9 million in Q2 2026; TTM through Apr 2026 was $28.7 million, a 3.74% decrease from a year earlier, with the FY2026 full-year figure at $29.1 million, up 0.87% from the prior year.
  • Depreciation & Amortization (CF) was little changed at $6.9 million in Q2 2026 per EXEL's latest filing, from $6.9 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $7.6 million in Q1 2025 and bottomed at $4.5 million in Q2 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $6.9 million (2023), against an average of $6.6 million.
  • Across the five-year window, Depreciation & Amortization (CF) soared 207.92% in 2022 and retreated 9.11% in 2026, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $5.9 million in 2022, then increased by 9.75% to $6.5 million in 2023, then advanced by 14.22% to $7.5 million in 2024, then retreated by 0.43% to $7.4 million in 2025, then fell by 6.39% to $6.9 million in 2026.
  • Per Business Quant, the three latest EXEL Depreciation & Amortization (CF) figures stand at $6.9 million (Q2 2026), $6.9 million (Q1 2026), and $7.4 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 6.95 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 6.95 Mn
Apr 3, 2026 6.95 Mn
Jan 2, 2026 6.95 Mn
Jan 2, 2026 6.95 Mn
Oct 3, 2025 7.42 Mn
Oct 3, 2025 7.42 Mn
Jul 4, 2025 7.34 Mn
Jul 4, 2025 7.34 Mn
Apr 4, 2025 7.35 Mn
Apr 4, 2025 7.35 Mn
Jan 3, 2025 7.64 Mn
Jan 3, 2025 7.64 Mn
Sep 27, 2024 7.45 Mn
Sep 27, 2024 7.45 Mn
Jun 28, 2024 7.33 Mn
Jun 28, 2024 7.33 Mn
Mar 29, 2024 6.38 Mn
Mar 29, 2024 6.38 Mn
Dec 29, 2023 6.53 Mn
Dec 29, 2023 6.53 Mn